Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Kalytera partners with Ramot for osteogenesis imperfecta treatment research

March 18, 2016

Orphan drug designation granted in Japan for tocilizumab in systemic scleroderma

March 18, 2016

Study results support every-other-month dosing of gerilimzumab for rheumatoid arthritis

March 18, 2016

ProMetic Life Sciences to explore use of PBI-4050 for scleroderma

March 16, 2016

BMS reports data on BMS-986142

March 14, 2016

Phase III data show sarilumab superior to adalimumab in patients with active rheumatoid arthritis

March 11, 2016

Han Wha Pharma and Yang Ji Chemical disclose JAK inhibitors

March 11, 2016

Xencor initiates phase II trials of XmAb-5871 for IgG4-related disease and SLE

March 8, 2016

Corbus to study Resunab for systemic lupus erythematosus

March 8, 2016

Antibe Therapeutics cleared to begin phase II study of ATB-346

March 7, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...